These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 404317)

  • 1. Cellular immunity in chronic Chagas' disease.
    Montufar OM; Musatti CC; Mendes E; Mendes NF
    J Clin Microbiol; 1977 Apr; 5(4):401-4. PubMed ID: 404317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired cell-mediated immunodepression in acute Chagas' disease.
    Teixeira AR; Teixeira G; Macêdo V; Prata A
    J Clin Invest; 1978 Dec; 62(6):1132-41. PubMed ID: 107195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M; de Titto E
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection.
    Cetron MS; Basilio FP; Moraes AP; Sousa AQ; Paes JN; Kahn SJ; Wener MH; Van Voorhis WC
    Am J Trop Med Hyg; 1993 Sep; 49(3):370-82. PubMed ID: 8372959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunology of experimental Chagas' disease. II. Delayed hypersensitivity to Trypanosoma cruzi antigens.
    Teixeira AR; Santos-Buch CA
    Immunology; 1975 Mar; 28(3):401-10. PubMed ID: 805088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro cellular immunity in Chagas' disease.
    Toledo Barros MA; Amato Neto V; Mendes E; Mota I
    Clin Exp Immunol; 1979 Nov; 38(2):376-80. PubMed ID: 118840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and partial characterization of Trypanosoma cruzi antigens recognized by T cells and immune sera from patients with Chagas' disease.
    Gazzinelli RT; Leme VM; Cancado JR; Gazzinelli G; Scharfstein J
    Infect Immun; 1990 May; 58(5):1437-44. PubMed ID: 2108932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in cell-mediated immunity to Trypanosoma cruzi during experimental Chagas' disease.
    Maleckar JR; Kierszenbaum F
    Ann Trop Med Parasitol; 1983 Jun; 77(3):247-54. PubMed ID: 6226246
    [No Abstract]   [Full Text] [Related]  

  • 9. Trypanosoma cruzi-sensitized T-lymphocyte mediated 51CR release from human heart cells in Chagas' disease.
    Teixeira AR; Teixeira G; Macêdo V; Prata A
    Am J Trop Med Hyg; 1978 Nov; 27(6):1097-1107. PubMed ID: 83110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular immune response from Chagasic patients to CRA or FRA recombinant antigens of Trypanosoma cruzi.
    Lorena VM; Verçosa AF; Machado RC; Moitinho-Silva L; Cavalcanti MG; Silva ED; Ferreira AG; Correa-Oliveira R; Pereira VR; Gomes YM
    J Clin Lab Anal; 2008; 22(2):91-8. PubMed ID: 18348314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Trypanosoma cruzi membrane protein shares an epitope with a lymphocyte activation antigen and induces crossreactive antibodies.
    Hernández-Munaín C; De Diego JL; Alcina A; Fresno M
    J Exp Med; 1992 Jun; 175(6):1473-82. PubMed ID: 1375261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte transformation in Chagas disease.
    Tschudi EI; Anziano DF; Dalmasso AP
    Infect Immun; 1972 Dec; 6(6):905-8. PubMed ID: 4629392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosoma cruzi-induced molecular mimicry and Chagas' disease.
    Gironès N; Cuervo H; Fresno M
    Curr Top Microbiol Immunol; 2005; 296():89-123. PubMed ID: 16323421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the cellular immune response in Chagas' disease patients.
    Castes M; Araujo Z; Mosca W
    Acta Cient Venez; 1986; 37(5):547-53. PubMed ID: 3129894
    [No Abstract]   [Full Text] [Related]  

  • 15. Longitudinal study of immune response in human Chagas' disease.
    Mosca W; Plaja J; Hubsch R; Cedillos R
    J Clin Microbiol; 1985 Sep; 22(3):438-41. PubMed ID: 3930564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed hypersensitivity to heart antigens in Chagas' disease as measured by in vitro lymphocyte stimulation.
    Mosca W; Plaja J
    J Clin Microbiol; 1981 Jul; 14(1):1-5. PubMed ID: 6790563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease.
    Souza PE; Rocha MO; Menezes CA; Coelho JS; Chaves AC; Gollob KJ; Dutra WO
    Infect Immun; 2007 Apr; 75(4):1886-94. PubMed ID: 17283096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated immunity in Chagas' disease: Alterations induced by treatment with a trypanocidal drug (nifurtimox).
    Lelchuk R; Cardoni RL; Fuks AS
    Clin Exp Immunol; 1977 Dec; 30(3):434-8. PubMed ID: 414867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated reactivity against human and Trypanosoma cruzi antigens according to clinical status in Chagas' disease patients.
    De Titto EH; Braun M; Lazzari JO; Segura EL
    Immunol Lett; 1985; 9(5):249-54. PubMed ID: 3922879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell mediated immunity in Chagas' disease. Trypanosoma cruzi antigens induce suppression of the in vitro proliferative response of mononuclear cells.
    Mosca W; Briceño L; Hernández MI
    Mem Inst Oswaldo Cruz; 1991; 86(2):147-52. PubMed ID: 1842408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.